Loes Jaspers1, Klodian Dhana1, Taulant Muka1, Cindy Meun1, Jessica C Kiefte-de Jong1, Albert Hofman1, Joop S E Laven1, Oscar H Franco1, Maryam Kavousi1. 1. Department of Epidemiology (L.J., K.D., T.M., J.C.K.-d.J., O.H.F., A.H., M.K.), Erasmus University Medical Centre, Rotterdam, 3000 CA The Netherlands; Division of Reproductive Medicine (C.M., J.S.E.L.), Department of Obstetrics and Gynaecology, Erasmus University Medical Centre, Rotterdam, 3000 CA The Netherlands; Leiden University College (J.C.K.-d.J.), The Hague, 3595 DG The Netherlands; and Department of Epidemiology (A.H.), Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02138.
Abstract
CONTEXT: The concept of cardiovascular health was recently introduced. Sex steroids and sex hormone-binding globulin (SHBG) influence different health domains, but no studies assessed their role in cardiovascular health. OBJECTIVE: To assess the association between estradiol (E2), testosterone (T), SHBG, and free androgen index (FAI) with cardiovascular health. DESIGN, SETTING, AND PARTICIPANTS: Analyses included 1647 men (68.6 y) and 1564 naturally postmenopausal women (69.6 y) with available data on sex steroids and cardiovascular health from the population-based Rotterdam Study. EXPOSURES: E2, T, SHBG, and FAI. OUTCOME: To define cardiovascular health, 7 metrics including 3 health factors (total cholesterol, fasting glucose, and blood pressure) and 4 health behaviors (physical activity, smoking, body mass index, and diet) were adopted. Three category levels of each metric were added up to a total score ranged 0-14. Logistic regression was performed to explore the association between E2, T, SHBG, and FAI and optimal cardiovascular health (OCH) (score of 11-14). RESULTS: OCH was reached by 153 men (9.3%) and 162 women (10.4%). The prevalence of OCH was higher in the lowest tertile of E2 (38.9%), and of T (43.8%), and the highest tertile of SHBG (48.1%) in women, and the highest tertile of T (43.1%) and SHBG (47.1%) in men. After adjustment for confounders, OCH was associated with lower T (odds ratio and 95% confidence interval, 0.69 [0.48-1.00]) and lower FAI (0.43 [0.32-0.57]) and higher levels of SHBG (4.55 [2.99-6.94]) among women and with higher levels of SHBG (2.56 [1.45-4.49]) in men. CONCLUSIONS: OCH was associated with sex steroids and with SHBG in both men and women. The complexity and temporality of the interrelation between sex steroids, SHBG, and cardiovascular health requires further investigation.
CONTEXT: The concept of cardiovascular health was recently introduced. Sex steroids and sex hormone-binding globulin (SHBG) influence different health domains, but no studies assessed their role in cardiovascular health. OBJECTIVE: To assess the association between estradiol (E2), testosterone (T), SHBG, and free androgen index (FAI) with cardiovascular health. DESIGN, SETTING, AND PARTICIPANTS: Analyses included 1647 men (68.6 y) and 1564 naturally postmenopausal women (69.6 y) with available data on sex steroids and cardiovascular health from the population-based Rotterdam Study. EXPOSURES: E2, T, SHBG, and FAI. OUTCOME: To define cardiovascular health, 7 metrics including 3 health factors (total cholesterol, fasting glucose, and blood pressure) and 4 health behaviors (physical activity, smoking, body mass index, and diet) were adopted. Three category levels of each metric were added up to a total score ranged 0-14. Logistic regression was performed to explore the association between E2, T, SHBG, and FAI and optimal cardiovascular health (OCH) (score of 11-14). RESULTS: OCH was reached by 153 men (9.3%) and 162 women (10.4%). The prevalence of OCH was higher in the lowest tertile of E2 (38.9%), and of T (43.8%), and the highest tertile of SHBG (48.1%) in women, and the highest tertile of T (43.1%) and SHBG (47.1%) in men. After adjustment for confounders, OCH was associated with lower T (odds ratio and 95% confidence interval, 0.69 [0.48-1.00]) and lower FAI (0.43 [0.32-0.57]) and higher levels of SHBG (4.55 [2.99-6.94]) among women and with higher levels of SHBG (2.56 [1.45-4.49]) in men. CONCLUSIONS: OCH was associated with sex steroids and with SHBG in both men and women. The complexity and temporality of the interrelation between sex steroids, SHBG, and cardiovascular health requires further investigation.
Authors: Lena Mathews; Vinita Subramanya; Di Zhao; Pamela Ouyang; Dhananjay Vaidya; Eliseo Guallar; Joseph Yeboah; David Herrington; Allison G Hays; Matthew J Budoff; Erin D Michos Journal: J Womens Health (Larchmt) Date: 2019-06-06 Impact factor: 2.681
Authors: Tracy E Madsen; Xi Luo; Mengna Huang; Ki E Park; Marcia L Stefanick; JoAnn E Manson; Simin Liu Journal: Stroke Date: 2020-02-12 Impact factor: 7.914
Authors: M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman Journal: Eur J Epidemiol Date: 2017-10-24 Impact factor: 8.082
Authors: Aya T Nanba; Juilee Rege; Jianwei Ren; Richard J Auchus; William E Rainey; Adina F Turcu Journal: J Clin Endocrinol Metab Date: 2019-07-01 Impact factor: 5.958
Authors: Sílvia Xargay-Torrent; Gemma Carreras-Badosa; Sara Borrat-Padrosa; Anna Prats-Puig; Pilar Soriano; Elena Álvarez-Castaño; Mª Jose Ferri; Francis De Zegher; Lourdes Ibáñez; Abel López-Bermejo; Judit Bassols Journal: PLoS One Date: 2018-10-15 Impact factor: 3.240
Authors: M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman Journal: Eur J Epidemiol Date: 2020-05-04 Impact factor: 8.082